The device has not been received for analysis.
Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
To reduce the potential for air ingress into the sheath and the risk of embolism, the polarsheath instructions for use (ifu) was revised to emphasize best practices during use of this device.
On april 13, 2021, boston scientific issued a field safety notice (b)(4) to communicate these ifu updates to all global customers in the interest of minimizing the risk of air embolism and promoting consistent use of the ifu in all geographies.
|
During an pulmonary vein isolation (pvi) cryoablation procedure to treat atrial fibrillation (af) a polarsheath was selected for use.
After bringing the polarsheath forward and removing the dilator, approximately 20ml of air was observed.
Angiography of all four veins was performed, the patient became bradycardic with st elevation.
Air embolism was diagnosed.
The artery which was blocked by air as recanalized.
The cryoablation procedure was cancelled and the patient was stable and transferred to intensive care unit for observation.
The patient has fully recovered.
The device is expected to be returned to boston scientific for analysis.
This product is part of the (b)(4) advisory population for the polarsheath steerable sheath.
|